Device / Technology News

RSS

UNAIDS launches online platform to highlight relevant research

"UNAIDS has launched an online platform, UNAIDS Science now, which highlights some of those papers that are particularly relevant to the United Nations high level targets," the agency reports in an article on its webpage.

24 Feb 2013

Clearview announces arrival of Catalys Precision Laser System in Southern CA

Clearview Eye & Laser Medical Center announces the arrival of the world's most sophisticated laser cataract surgery system in Southern CA.

24 Feb 2013

UAB becomes first in America to test experimental therapy for emphysema

A patient at the University of Alabama at Birmingham (UAB) became the first person in America to undergo an investigational therapy for emphysema that uses a foam sealant sprayed into the lungs.

23 Feb 2013

PANO-VAC launches new products for general surgeries and dentistry

PANO-VAC Surgical Instruments, Inc. is pleased to announce the launch of our new products that are useful in general surgeries and dentistry, RetractorPlus and AspiratorPlus.

23 Feb 2013

Washington University creates new type of air-cleaning technology

Washington University engineering researchers have created a new type of air-cleaning technology that could better protect human lungs from allergens, airborne viruses and ultrafine particles in the air.

23 Feb 2013

EO2 Concepts develops innovative dressing for difficult-to-heal wounds

EO2 Concepts has developed an innovative dressing for difficult-to-heal wounds that is as easy to apply as a Band-Aid.

23 Feb 2013

EnvisionTEC launches 3Dent for manufacture of dental models

EnvisionTEC, a leading manufacturer and distributor of patented 3D rapid prototyping and manufacturing solutions, unveiled the newest addition to its dental lineup, 3Dent, specifically for the manufacture of dental models.

23 Feb 2013

Genetic testing expansion results in urgent need for national policy

The Royal College of Pathologists of Australasia (RCPA) has announced new findings from nationwide research on the country’s genetic testing. The RCPA was contracted in 2012 by the Department of Health and Ageing to conduct its second survey on genetic testing. The findings were analysed by spokesperson on genetic testing for the RCPA, Professor Graeme Suthers, and Dr Kym Mina, Genetic Pathologist and Project Officer for the survey.

22 Feb 2013

Dako, Panagene sign supply agreement for PNA oligomer component

Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako's diagnostic or research products. Dako, an Agilent Technologies Company since June 2012, is a leading global provider of tissue-based cancer diagnostic solutions.

22 Feb 2013

Florida Hospital Pepin Heart Institute, USF partner for novel gene therapy trial

Cardiovascular disease specialists at Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute affiliated with the University of South Florida announced they have enrolled their first patients into a clinical trial testing a novel gene therapy for the treatment of heart failure after ischemic injury. The therapy may promote the regeneration of heart tissue by encouraging the body to deploy more stem cells to the injury site.

22 Feb 2013

Research into why young adults overuse short-acting bronchodilators

The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.

22 Feb 2013

New leprosy test, experimental vaccine might hasten disease elimination, Slate reports

Slate examines a new rapid diagnostic test and an experimental vaccine for leprosy, both developed by the Infectious Disease Research Institute in Seattle, writing, "The two tools together could finally free humans from the vicious cycle of a disease that has afflicted the population for at least 4,000 years."

22 Feb 2013

IntegraGen, Lab21 collaborate to develop new microRNA assay for colorectal cancer

Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes.

22 Feb 2013

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Breast cancer is a major concern throughout the world. It is the number 1 cancer among women and in the Western world it generates approximately one new case per minute: 24 hours a day 7 days a week.

22 Feb 2013

Researchers use 3D printing and injectable gels to create bioengineered ears

Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. Researchers believe their bioengineering method will finally succeed in the long quest by scientists and physicians to provide normal looking "new" ears to thousands of children born with a congenital ear deformity.

22 Feb 2013

Antibody delivery system launched that works even in presence of additives

...

22 Feb 2013

Catheters may increase risk of death, infections and cardiovascular events in dialysis patients

Dialysis patients using catheters to access the blood have the highest risks for death, infections, and cardiovascular events compared with patients using other types of vascular access, according to an analysis appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

22 Feb 2013

Brain cooling after severe head injury may prevent epileptic seizures

In the weeks, months and years after a severe head injury, patients often experience epileptic seizures that are difficult to control. A new study in rats suggests that gently cooling the brain after injury may prevent these seizures.

22 Feb 2013

Syneron dismisses U.S. patent infringement suit against Eclipse Aesthetics, EndyMed

Syneron Medical Ltd., the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products.

22 Feb 2013

FDA approves new vial size for CSL Behring’s Privigen to treat primary immunodeficiency

CSL Behring today announced that the United States Food and Drug Administration has approved a 40 g (400 mL) vial size for Privigen, immune globulin intravenous [human].

21 Feb 2013